# Avista Pharma Solutions, Inc. dba Cambrex - Inspection Records

Source: https://www.keypedia.com/companies/avista-pharma-solutions-inc-dba-cambrex/ca9e4205-cd7f-44bd-8dbe-a9d98be57047

> Inspection records and compliance data for Avista Pharma Solutions, Inc. dba Cambrex in Longmont, Colorado. Access full analysis and detailed observations.

---

## Details

- Name: Avista Pharma Solutions, Inc. dba Cambrex
- FEI Number: 3012316957
- City: Longmont
- State: Colorado
- Country Name: United States
- Address Line 1: 2620 Trade Centre Ave
- Zip Code: 80503
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING

## Related Documents

- [483 - Avista Pharma Solutions, Inc. dba Cambrex - 2024-05-03](https://www.keypedia.com/records/483/avista-pharma-solutions-inc-dba-cambrex/2fe9902d-f385-45a9-bfe8-88b27afa5385) — source: FDA, date: May 3, 2024
- [FDA Inspection 1237587 - Avista Pharma Solutions, Inc. dba Cambrex - 2024-05-03](https://www.keypedia.com/records/fda_inspections/avista-pharma-solutions-inc-dba-cambrex/0b0b6fab-e480-4edd-95fe-6c322c0023e9) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 3, 2024
- [FDA Inspection 1237587 - Avista Pharma Solutions, Inc. dba Cambrex - 2024-05-03](https://www.keypedia.com/records/fda_inspections/avista-pharma-solutions-inc-dba-cambrex/d49d28da-b239-4a0c-8f51-8a56a673d5d4) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 3, 2024
- [EIR - Avista Pharma Solutions, Inc. dba Cambrex - 2018-11-09](https://www.keypedia.com/records/eir/avista-pharma-solutions-inc-dba-cambrex/167b58b2-f867-4129-9f5c-c4d4237e5b90) — source: FDA, date: November 9, 2018

## Related Companies

- [Alexion Pharma International Operations Unlimited Co.](https://www.keypedia.com/companies/alexion-pharma-international-operations-unlimited-co/7c523c79-b4b1-4a47-8393-141753fd60e8)
- [Brammer Bio MA, LLC](https://www.keypedia.com/companies/brammer-bio-ma-llc/df01a45e-77d0-4179-bd95-978ebd2395a6)
- [Wacker Biotech B.V.](https://www.keypedia.com/companies/wacker-biotech-bv/9bd47c05-6585-4710-a9ea-4bd04e15dd4f)
- [Symbiosis Pharmaceutical Services Limited](https://www.keypedia.com/companies/symbiosis-pharmaceutical-services-limited/ec055812-aec1-48cd-a034-44081f00bf5f)
- [Zoetis Belgium SA](https://www.keypedia.com/companies/zoetis-belgium-sa/7523c8e2-686d-4725-80d2-2c1ca3109717)
- [Boehringer Ingelheim Biopharmaceuticals (China) Ltd.](https://www.keypedia.com/companies/boehringer-ingelheim-biopharmaceuticals-china-ltd/be450a8b-4f71-4f06-96b3-908a2ed1b580)
- [AGC Biologics SPA](https://www.keypedia.com/companies/agc-biologics-spa/aca43856-193e-492b-9512-0f72b2680e90)
- [ANTHEM BIOSCIENCES PRIVATE LIMITED - Phase II](https://www.keypedia.com/companies/anthem-biosciences-private-limited-phase-ii/df5d2c40-b402-492b-9369-42c7f15f0a08)
- [VGXI, Inc.](https://www.keypedia.com/companies/vgxi-inc/74b43bde-de6a-4ab6-825e-e8f3598e221f)
- [Genzyme Corporation](https://www.keypedia.com/companies/genzyme-corporation/b597b205-d758-426b-bc64-09970b3a1b83)

## Related Officers

- [recipient](https://www.keypedia.com/people/kenneth-a-domagalski/028372e6-473d-4e21-8d67-82545c4452fc)
- [company_representative](https://www.keypedia.com/people/cathy-butler/169437e3-ea7c-4842-80fe-a3955c795e98)
- [Michael S Budziak](https://www.keypedia.com/people/michael-s-budziak/23634aff-ee10-4f94-a4c1-2cf9dd4922bc)
- [Cecilia H. Kieu](https://www.keypedia.com/people/cecilia-h-kieu/3ba5feb0-d49e-4301-ae5c-b84bd604a159)